Adjuvante Therapie des Melanoms-Reference-Cited by-同舟云学术

Adjuvante Therapie des Melanoms

Published:2006-09 Issue:9 Volume:57 Page:764-772
ISSN:0017-8470
Container-title:Der Hautarzt
language:de
Short-container-title:Hautarzt

Author:

Hauschild A.,Kleeberg U. R.

Publisher

Springer Science and Business Media LLC

Subject

Dermatology

Link

http://link.springer.com/content/pdf/10.1007/s00105-006-1196-6.pdf

Reference27 articles.

1. Balch CM, Hersey P (1988) Heutiger Stand der adjuvanten Therapie. In: Balch CM, Milton GW, Shaw HM et al. (Hrsg) Hautmelanome. Diagnose, Therapie und weltweite Ergebnisse. Springer, Berlin Heidelberg New York, S 192–212

2. Balch CM, Buzaid AC, Soong SJ et al. (2001) Final version of the American Joint Committee on Cacer staging system for cutaneous melanoma. J Clin Oncol 15: 3535–3648

3. Cameron DA, Cornbleet MC, MacKie RM et al. (2001) Adjuvant interferon alpha 2b in high risk melanoma – the Scottish study. Br J Cancer 84: 1146–1149

4. Cascinelli N, Belli F, MacKie RM et al. (2001) Effect of long-term adjuvant therapy with interferon alpha-2a in patients with regional node metastases from cutaneous melanoma: a randomized trial. Lancet 358: 866–869

5. Creagan ET, Dalton RJ, Ahmann DL et al. (1995) Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma. J Clin Oncol 13: 2776–2783

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current World Literature;Current Opinion in Oncology;2008-03

2. Survival Benefit with GM-CSF Use after High-Dose Chemotherapy in High-Risk Breast Cancer;Tumori Journal;2007-11

3. Cytokine Therapy for Cancer;Surgical Oncology Clinics of North America;2007-10